Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascentage, Astrazeneca, Cansino Biologics, Eli Lilly, Henlius, Innovent, Kyowa Kirin, Mei, Neuren, Novavax, Takeda, Xcovery.